Trial Profile
Phase II-III Trial of Adjuvant Radiotherapy Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 30 Mar 2023
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Bicalutamide; Flutamide; Goserelin; Leuprorelin; Nilutamide
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 07 Sep 2022 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2017 New trial record